American Heart Association Journals
AHA Journals at AHA Scientific Sessions 2025 Streamlining the Pathway to Publish Cardiovascular Research Learn more about Circulation 's collaboration with NEJM Circulation …
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the …
Feb 27, 2025 · Progressive lipid accumulation and inflammation within an atherosclerotic plaque may lead to plaque instability. Rupture or erosion of the atherosclerotic plaque and exposure …
Vol 152, No 21 | Circulation - AHA/ASA Journals
Nov 25, 2025 · Explore the latest research and articles on cardiovascular health and disease in Circulation's current issue.
Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel …
Feb 24, 2025 · Circulation. 2010;121:306–314. doi: 10.1161/CIRCULATIONAHA.109.900027 44. Helske-Suihko S, Laine M, Lommi J, Kaartinen M, Werkkala K, Kovanen PT, Kupari M. Is …
Vol 151, No 2 | Circulation - AHA/ASA Journals
Jan 14, 2025 · Recognized Outstanding Reviewers for Circulation in 2024 Darren K. McGuire, James A. de Lemos, Joseph A. Hill, on behalf of the Circulation Editors Team PDF Full Text
2025 Heart Disease and Stroke Statistics: A Report of US and …
Jan 27, 2025 · Circulation Volume 151, Number 8 https://doi.org/10.1161/CIR.0000000000001303 160,211 262
2025 High Blood Pressure Guidelines - AHA/ASA Journals
Aug 14, 2025 · Published jointly in Hypertension and Circulation. The 2025 AHA/ACC High Blood Pressure Guideline reflects the latest recommendations and advancements in hypertension …
American Heart Association Journals
Circulation: Heart Failure presents Waveforms, our blog highlighting what’s new and what’s important about papers coming out in the journal. Latest Posts
Update on Diagnosis and Management of Kawasaki Disease: A …
Nov 13, 2024 · Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. …
Dapagliflozin to Reduce Early Recurrence After Catheter Ablation …
Nov 9, 2025 · Background: Observational studies have suggested that sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with a lower risk of atrial fibrillation (AF) …